Julia K. York

Selected experience includes defending or representing:

• Activision Blizzard, Inc. in a lawsuit brought by the Federal Trade Commission (FTC) challenging the proposed acquisition of the company by Microsoft
• Apple Inc. in:
  • two lawsuits brought by an advertiser purporting to represent a class and by a group of consumers, both alleging that Apple and Google engaged in a horizontal conspiracy not to compete in the “search business”
  • the Department of Justice’s lawsuit against Google (United States v. Google)
• Greystar Management Services LLC in an antitrust action by the District of Columbia attorney general alleging that multifamily property managers inflated rents through the use of Real Page revenue management software
• Norfolk Southern Railway Co. in a federal antitrust case alleging that the company and three other major U.S. freight railroads conspired to charge supracompetitive fuel charges
• Actavis, Inc., Teva Pharmaceuticals USA, Inc. and a Teva Pharmaceuticals USA, Inc. affiliate in “reverse-payment” litigations related to the brand-name drug AndroGel 1%
• subsidiaries of Glencore in antitrust class actions concerning warehousing and trading of aluminum and zinc
• Visa Inc. in the Justice Department’s challenge to its proposed acquisition of Plaid Inc.
• Sabre Corporation in the Justice Department’s challenge to its proposed acquisition of FareLogix
• Anheuser Busch InBev in a lawsuit brought by a Wisconsin-based brewery alleging a conspiracy to restrain trade in the Ontario beer market
• Sprint Corp. in a lawsuit brought by state attorneys general challenging the proposed acquisition of Sprint by T-Mobile
• Actavis, Inc. in a suit brought by the FTC, including before the U.S. Supreme Court, challenging the legality of a patent litigation settlement
• Medicis Pharmaceutical Corp. and Valeant Pharmaceuticals International Inc. in multidistrict “reverse-payment” class action litigation related to the acne product Solodyn
• Johnson-Matthey in a suit brought by Actelion Pharmaceuticals Ltd. against multiple prospective generic manufacturers involving monopolization and restraint of trade claims in connection with Actelion’s REMS and restricted pharmaceutical distribution programs
• brand-name and generic pharmaceutical companies in connection with FTC investigations and inquiries
• a pharmaceutical company CEO in a challenge to an FTC investigation
• Nokia in an antitrust challenge to its IP licensing practices
• Energy Transfer Partners in the successful defense of an antitrust class action in the Texas natural gas market

Ms. York is the outgoing vice chair of the ABA Antitrust Section’s Antitrust Law Developments Committee and regularly appears on discussion panels on antitrust issues relevant to the pharmaceutical industry. She is co-chair of Skadden’s Washington, D.C. women’s affinity group and actively works on pro bono matters, including a recent win before the D.C. Circuit on behalf of a putative class of racial justice protestors, and representing various amici curiae on briefs submitted to the U.S. Supreme Court and U.S. Circuit Courts of Appeals. Ms. York has been named repeatedly as one of Lawdragon’s 500 Leading Litigators in America and 500 Leading Lawyers in America. She also has been recognized in The Legal 500 U.S. and Best Lawyers in America.

Prior to joining Skadden, Ms. York counseled clients from diverse industries in connection with DOJ and FTC investigations into mergers and acquisitions. Other prior experience included representing a television industry client in a DOJ criminal price-fixing investigation, as well as representing a telecommunications industry client and an aluminum industry client in international arbitration proceedings in Switzerland.